Joerg Thomas Regula

USPTO Granted Patents = 49 (Patent Applications = 57)

CIPO Patents = 11 (Patent Applications = 15)

EPO Patents = 34 (Patent Applications = 51)

Average Co-Inventor Count = 8.5

ph-index = 11

Forward Citations = 380(Granted Patents)

Location History:

Penzberg, DE (2019 - 2021)
Munich, DE (2009 - 2024)

Company Filing History:

39 out of 4,945

Hoffmann-la Roche Inc.

Bristol-myers Squibb Compnay

patents

where one patent can have more than one assignee

Years Active: 2009-2025

Loading Chart...

Areas of Expertise:

Bispecific Antibodies

Tumor Necrosis Factor

Antigen-Binding Molecules

Trispecific Binding Proteins

T Cell Activating Molecules

Ocular Vascular Diseases

Human Angiopoietin 2

Fc-Receptor Binding

Monovalent Antigen Binding

Insulin-Like Growth Factor

PD1 and TIM3

Anti-VEGF Antibodies

49 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12441812 - Methods of treating cancer by administering tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules (2025-10-14),

2. 12391757 - Bispecific antibodies specific for PD1 and TIM3 (2025-08-19),

3. 12358997 - Bispecific anti-human A-beta/anti-human transferrin receptor antibodies (2025-07-15),

4. 12264196 - Fc-receptor binding modified asymmetric antibodies and methods of use (2025-04-01),

5. 12227573 - Trispecific binding proteins, methods, and uses thereof (2025-02-18),

6. 12030952 - Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use (2024-07-09),

7. 11952421 - Bispecific antibodies against CD3EPSILON and ROR1 (2024-04-09),

8. 11787868 - Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use (2023-10-17),

9. 11673945 - Bispecific antigen binding proteins (2023-06-13),

10. 11613576 - Trispecific binding proteins, methods, and uses thereof (2023-03-28),

11. 11603411 - Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use (2023-03-14),

12. 11306154 - Methods of treating cancer by administering antigen-binding molecules comprising a TNF family ligand trimer (2022-04-19),

13. 11267903 - Antigen-binding molecules comprising a tumor necrosis factor (TNF) family ligand trimer (2022-03-08),

14. 11130810 - Bispecific antibodies specific for PD1 and TIM3 (2021-09-28),

15. 11117965 - Bispecific T cell activating antigen binding molecules (2021-09-14),

Title: Joerg Thomas Regula - Innovative Inventor from Munich

Introduction: Joerg Thomas Regula is a renowned inventor hailing from Munich, Germany, known for his groundbreaking contributions to various technological fields.

Latest Patents: Joerg Thomas Regula holds several patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Joerg Thomas Regula has worked with leading research institutions and tech companies, consistently pushing the boundaries of innovation and creating solutions to complex problems.

Collaborations: Throughout his career, Joerg Thomas Regula has collaborated with top engineers, scientists, and designers, fostering a culture of creativity and excellence in all his projects.

Conclusion: Joerg Thomas Regula's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and shape the future of various industries.

This text is generated by artificial intelligence and may not be accurate.